Results 171 to 180 of about 10,897 (217)
Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia
Brain, 2015 A Spanish group recently reported that four patients with chronic inflammatory demyelinating polyneuropathy carrying IgG4 autoantibodies against contactin 1 showed aggressive symptom onset and poor response to intravenous immunoglobulin.
Jérôme Devaux +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Chronic inflammatory demyelinating polyneuropathy and diabetes
Journal of Neurology, Neurosurgery & Psychiatry, 2020CIDP is a most common chronic immune-mediated demyelinating neuropathy, but still a rare disease; the reported prevalence ranges from 0.8 to 8.9 per 100 000 people.1 The different prevalence among the studies is partly dependent on diagnostic criteria and CIDP subtypes.
Satoshi Kuwabara +2 more
openaire +2 more sources
Diagnosis of chronic inflammatory demyelinating polyneuropathy
Muscle & Nerve, 2022AbstractChronic inflammatory demyelinating polyneuropathy (CIDP) is a chronic immune‐mediated peripheral form of polyneuropathy. No reliable diagnostic biomarkers are available by which to make the diagnosis of CIDP. As a result, diagnosis of the condition can be challenging.
Jeffrey A. Allen, Richard A. Lewis
openaire +2 more sources
Fatigue in chronic inflammatory demyelinating polyneuropathy
Muscle & Nerve, 2020AbstractIntroductionIn this study we aimed to better understand fatigue in chronic inflammatory demyelinating polyneuropathy (CIDP) as it relates to disease activity status.MethodsPatients with probable or definite CIDP were stratified into active CIDP or CIDP in remission.
Karissa L, Gable +2 more
openaire +2 more sources
Chronic inflammatory demyelinative polyneuropathy
2013Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired polyneuropathy presumably of immunological origin. It is characterized by a progressive or a relapsing course with predominant motor deficit. The diagnosis rests on the association of non-length-dependent predominantly motor deficit following a progressive or a relapsing course ...
Said, Gérard, Krarup, Christian
openaire +3 more sources
Chronic inflammatory demyelinating polyneuropathy
Neuromuscular Disorders, 2006Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired neuropathy, presumably of immunological origin. Its clinical presentation and course are extremely variable. CIDP is one of the few peripheral neuropathies amenable to treatment. Typical cases associate progressive or relapsing-remitting motor and sensory deficit with increased CSF
openaire +3 more sources
Chronic inflammatory demyelinating polyneuropathy
Current Treatment Options in Neurology, 2003Although there are close to 10 randomized trials showing efficacy for prednisone, intravenous immunoglobulin, or plasmapheresis in chronic inflammatory demyelinating polyneuropathy (CIDP), large differences in cost, side effect profiles, and ease of use create controversy over the therapy that is best.
Jonathan S., Katz, David S., Saperstein
openaire +2 more sources
Chronic inflammatory demyelinating polyneuropathy
Current Opinion in Neurology, 2007Purpose of review As a syndrome with typical and atypical cases, chronic inflammatory demyelinating polyneuropathy (CIDP) has been a difficult disorder to diagnose and treat. The pathophysiologic basis for CIDP has not been established, contributing to the challenges in dealing with these patients.
openaire +3 more sources
Chronic inflammatory demyelinating polyneuropathy
Current Treatment Options in Neurology, 1999Treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) requires long-term immunomodulatory therapy, which has potential side effects. Before such therapy is instituted, a firm diagnosis of CIDP must be established. Prednisone, plasma exchange (PE), and intravenous immunoglobulin (IVIG) are all proven first-line therapies for CIDP that ...
, Gorson, , Chaudhry
openaire +2 more sources
The spectrum of chronic inflammatory demyelinating polyneuropathy
Journal of the Neurological Sciences, 2000Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP) were proposed by an Ad Hoc Subcommittee of the American Academy of Neurology (AAN) in 1991, and since then these criteria have been widely used in clinical studies.
F T, Rotta +5 more
openaire +2 more sources